Ignite Creation Date:
2024-05-06 @ 2:15 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT02000440
Status:
COMPLETED
Last Update Posted:
2017-06-12
First Post:
2013-11-27
Brief Title:
A Phase II Repeat Dose Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis FSGS
Sponsor:
Organization:
GlaxoSmithKline